- Butacaine
- Butacaine sulfate
- 14916-60-0Pyridine, 2,3-dinitro-
- 14916-61-1Pyridine, 2,4-dinitro-
- 14916-63-32-Pyridinamine,6-nitro-
- 14916-64-44-Pyridinamine,2-nitro-
- 14916-65-55-Amino-2-nitropyridine
- 14916-69-9Pyridine, 3,4-dinitro-
- 14916-79-13-Heptyn-1-ol
- 14916-80-43-Octyn-1-ol
- 14918-21-95-Hexynenitrile
- 149182-72-93-Isoquinolinecarboxamide,N-(1,1-dimethylethyl)-1,2,3,4-tetrahydro-, (3S)-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Butacaine |
EINECS | N/A |
| CAS No. | 149-16-6 | Density | 1.014g/cm3 |
| PSA | 55.56000 | LogP | 4.29910 |
| Solubility | N/A | Melting Point |
25°C |
| Formula | C18H30 N2 O2 | Boiling Point | 440°C at 760 mmHg |
| Molecular Weight | 306.448 | Flash Point | 219.9°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | A poison via subcutaneous and intravenous routes. A weak allergen. Combustible. When heated to decomposition it emits toxic fumes of NOx. See also BUTACAINE SULFATE. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
1-Propanol,3-(dibutylamino)-, 4-aminobenzoate (ester) (9CI); 1-Propanol,3-(dibutylamino)-, p-aminobenzoate (7CI); 1-Propanol, 3-(dibutylamino)-,p-aminobenzoate (ester) (8CI); Butacaine (6CI); 3-(Dibutylamino)-1-propanolp-aminobenzoate; 3-(p-Aminobenzoxy)-1-di-n-butylaminopropane;3-Dibutylaminopropyl p-aminobenzoate; Butelline; Butyn |
Butacaine Chemical Properties
Chemistry informtion about Butacaine(CAS NO.149-16-6) is:
IUPAC Name: 3-(dibutylamino)propyl 4-aminobenzoate
Synonyms: 1-Propanol, 3-(dibutylamino)-, 4-aminobenzoate ; 1-Propanol, 3-(dibutylamino)-, 4-aminobenzoate (ester) ; 1-Propanol, 3-(dibutylamino)-, p-aminobenzoate ; 1-Propanol, 3-(dibutylamino)-, p-aminobenzoate (ester) ; 3-(Dibutyamino)-1-propanol-p-aminobenzoate (ester) ; 3-(dibutylamino)-1-propano4-aminobenzoate(ester) ; 3-(Dibutylamino)-1-propanol p-aminobenzoate ; 3-(dibutylamino)-1-propanolp-aminobenzoate
Molecular Weight: 306.443 [g/mol]
Molecular Formula: C18H30N2O2
XLogP3: 4.5
H-Bond Donor: 1
H-Bond Acceptor: 4
EINECS: 205-734-7
Density: 1.014 g/cm3
Flash Point: 219.9 °C
Enthalpy of Vaporization: 69.7 kJ/mol
Boiling Point: 440 °C at 760 mmHg
Vapour Pressure: 6.1E-08 mmHg at 25°C
Storage temp.: −20°C
Following is the molecular structure of Butacaine(CAS NO.149-16-6) is:
Butacaine Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LDLo | intravenous | 15mg/kg (15mg/kg) | American Journal of Physiology. Vol. 68, Pg. 110, 1924. | |
| cat | LDLo | subcutaneous | 30mg/kg (30mg/kg) | behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: respiratory stimulation lungs, thorax, or respiration: other changes | Journal of Pharmacology and Experimental Therapeutics. Vol. 24, Pg. 167, 1925. |
| dog | LDLo | subcutaneous | 55mg/kg (55mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
| frog | LDLo | intraspinal | 30mg/kg (30mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 45, Pg. 291, 1932. | |
| guinea pig | LDLo | subcutaneous | 45mg/kg (45mg/kg) | peripheral nerve and sensation: flaccid paralysis without anesthesia (usually neuromuscular blockage) behavioral: convulsions or effect on seizure thresholdbehavioral: changes in motor activity (specific assay) | Journal of Pharmacology and Experimental Therapeutics. Vol. 62, Pg. 69, 1938. |
| mouse | LDLo | intravenous | 12mg/kg (12mg/kg) | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 39, Pg. 4, 1950. | |
| mouse | LDLo | subcutaneous | 50mg/kg (50mg/kg) | Journal of the American Chemical Society. Vol. 61, Pg. 3562, 1939. | |
| rabbit | LDLo | intravenous | 12mg/kg (12mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
| rabbit | LDLo | subcutaneous | 50mg/kg (50mg/kg) | behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: respiratory stimulation lungs, thorax, or respiration: other changes | Journal of Pharmacology and Experimental Therapeutics. Vol. 24, Pg. 167, 1925. |
| rat | LDLo | intravenous | 7500ug/kg (7.5mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
| rat | LDLo | subcutaneous | 150mg/kg (150mg/kg) | behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: respiratory stimulation lungs, thorax, or respiration: other changes | Journal of Pharmacology and Experimental Therapeutics. Vol. 24, Pg. 167, 1925. |
Butacaine Safety Profile
A poison via subcutaneous and intravenous routes. A weak allergen. Combustible. When heated to decomposition it emits toxic fumes of NOx. See also BUTACAINE SULFATE.
RIDADR: 3249
WGK Germany: 3
RTECS: UB0875000
HazardClass: 6.1(b)
PackingGroup: III
Butacaine Specification
Butacaine(CAS NO.149-16-6) is a local anesthetic.
What can I do for you?
Get Best Price
